| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JM00180A019 |
| P698 | PubMed publication ID | 6156240 |
| P2093 | author name string | G W Pasternak | |
| E F Hahn | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 674-676 | |
| P577 | publication date | 1980-06-01 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Long-acting opiate agonists and antagonists: 14-hydroxydihydromorphinone hydrazones | |
| P478 | volume | 23 |
| Q44345218 | 14 beta-Chlorocinnamoylamino derivatives of metopon: long-term mu-opioid receptor antagonists |
| Q36374248 | Classification of multiple morphine and enkephalin binding sites in the central nervous system |
| Q52297184 | Developmental differences between high and low affinity opiate binding sites: Their relationship to analgesia and respiratory depression |
| Q44345097 | Differential sensitivity of opioid-induced feeding to naloxone and naloxonazine |
| Q40085590 | Endogenous opiates: 1980 |
| Q44351808 | Evidence that naloxonazine produces prolonged antagonism of central delta opioid receptor activity in vivo |
| Q34001543 | Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor |
| Q49018078 | Increased biological activity of dimers of oxymorphone and enkephalin: Possible role of receptor crosslinking |
| Q51854331 | Irreversible Ligands with High Selectivity Toward δ and μ Opiate Receptors |
| Q34253970 | Metkephamid (Tyr-D-Ala-Gly-Phe-N(Me)Met-NH2), a potent opioid peptide: Receptor binding and analgesic properties |
| Q37236111 | Mu opioids and their receptors: evolution of a concept |
| Q72903604 | Naloxazone irreversibly inhibits the high affinity binding of [125I]D-ala2-D-leu5-enkephalin |
| Q34253900 | Naloxonazine, a potent, long-lasting inhibitor of opiate binding sites |
| Q52061969 | Naloxone-6 alpha-spirohydantoin: a long-acting opiate antagonist. |
| Q44352975 | Ontogeny of opioid pharmacology and receptors: High and low affinity site differences |
| Q34251510 | Opiate Analgesia: Evidence for Mediation by a Subpopulation of Opiate Receptors |
| Q72912832 | Opiates and enkephalins: A common binding site mediates their analgesic actions in rats |
| Q44352202 | Opioid binding profiles of new hydrazone, oxime, carbazone and semicarbazone derivatives of 14-alkoxymorphinans. |
| Q39765633 | Opioids and sexual behavior |
| Q34250337 | Oxymorphazone: A long-acting opiate analgesic |
| Q44342176 | Prolonged receptor blockade by opioid receptor probes |
| Q28262450 | Receptor binding and analgesic properties of oxymorphazone |
| Q44353442 | Spinal and supraspinal opioid analgesia in the mouse: the role of subpopulations of opioid binding sites |
| Q44342170 | Synthesis and pharmacological characterization of fluorescent opioid receptor probes |
| Q44350044 | Synthesis, Pharmacology, and Molecular Docking Studies on 6-Desoxo-N-methylmorphinans as Potent μ-Opioid Receptor Agonists |
| Q72903597 | The actions of naloxazone on the binding and analgesic properties of morphiceptin (NH2 Tyr-Pro-Phe-Pro-CONH2), a selective mu-receptor ligand |
| Q51723786 | The growth hormone secretory response to fentanyl in rat: an involvement of mu type receptors. |
Search more.